Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul-Aug;109(7-8):311-316.

Prevalence and Mortality of Melanoma in Oklahoma Among Racial Groups, 2000-2008

Jonathan Baldwin  1 , Amanda E Janitz  1 , Julie Erb-Alvarez  2 , Cuyler Snider  3 , Janis E Campbell  1
Affiliations

Prevalence and Mortality of Melanoma in Oklahoma Among Racial Groups, 2000-2008

Jonathan Baldwin et al. J Okla State Med Assoc. 2016 Jul-Aug.

Abstract

Introduction: This study assessed the period prevalence (2000-2008) and mortality rates of melanoma, in Oklahoma, among different racial/ethnic strata.

Methods: We analyzed incident cases of melanoma from 2000-2008 from the Oklahoma Central Cancer Registry and determined disease duration using Kaplan-Meier survival analysis to calculate period prevalence of melanoma in Oklahoma. Using a series of Chi-Square tests, we compared period prevalence and mortality rates among the racial groups and compared mortality between Oklahoma and the US.

Results: White non-Hispanics in Oklahoma have the highest period prevalence (p<0.0001) among the racial strata. American Indian or Alaska Native (AI/AN) individuals have the second highest period prevalence in Oklahoma (p<0.0001). Furthermore, white non-Hispanics (p<0.0001) and AI/AN individuals (p=0.0003) in Oklahoma had higher mortality rates compared to the US.

Conclusions: There are disparities in the prevalence and mortality of melanoma among the AI/AN population in Oklahoma, and prevention and education programs should focus on this population.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overall survival among those with incidence cases of melanoma (n=6,846) by race/ethnicity in Oklahoma, 2000-2008.
See this image and copyright information in PMC

References

    1. Busam KJ, Barnhil RL, Piepkorn MW. Melanocytes. In: Barnhill RL, Peipkorn MW, Busam KJ, editors. Pathology of Melanocytic Nevi and Melanoma. Springer; Verlag, Berlin, Heidelberg: 2014.
    1. Geller AC. Educational and Screening Campaigns to Reduce Deaths from Melanoma. Hematol Oncol Clin N Am. 2009;23:515–527. - PubMed
    1. Garbe C, Leiter U. Melanoma epidemiology and trends. Clin Dermatol.i. 2009;27:3–9. - PubMed
    1. Gloster HM, Neal K. Skin Cancer in skin of color. J Am Acad Dermatol. 2006;55:741–760. - PubMed
    1. Livingstone E, Krajewski C, Eigentler TK, Windemuth-Kieselbach C, Benson S, Elsenbruch S, Hauschild A, Rompel R, Meiss F, Mauerer A, Kahler KC, Dippel E, Mollenhoff K, Kilian K, Mohr P, Utikal J, Schadendorf D. Prospective evaluation of follow-up in melanoma patients in Germany - results of a multicentre and longitudinal study. Eur J Cancer. 2015;51(5):653–67. - PubMed

Publication types

LinkOut - more resources